17-38298597-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The ENST00000613675.5(MRPL45):c.215C>T(p.Ser72Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000265 in 151,216 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
ENST00000613675.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRPL45 | NM_032351.6 | c.215C>T | p.Ser72Leu | missense_variant | 2/8 | ENST00000613675.5 | NP_115727.5 | |
MRPL45 | NM_001278279.3 | c.215C>T | p.Ser72Leu | missense_variant | 2/7 | NP_001265208.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MRPL45 | ENST00000613675.5 | c.215C>T | p.Ser72Leu | missense_variant | 2/8 | 1 | NM_032351.6 | ENSP00000484903.1 | ||
MRPL45 | ENST00000619548.1 | c.215C>T | p.Ser72Leu | missense_variant | 2/7 | 3 | ENSP00000478397.1 |
Frequencies
GnomAD3 genomes AF: 0.0000265 AC: 4AN: 151216Hom.: 0 Cov.: 28
GnomAD3 exomes AF: 0.0000249 AC: 6AN: 241276Hom.: 0 AF XY: 0.0000380 AC XY: 5AN XY: 131598
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000205 AC: 30AN: 1461264Hom.: 0 Cov.: 31 AF XY: 0.0000261 AC XY: 19AN XY: 726960
GnomAD4 genome AF: 0.0000265 AC: 4AN: 151216Hom.: 0 Cov.: 28 AF XY: 0.0000271 AC XY: 2AN XY: 73760
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 20, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at